Abstract SY45-04: Development of therapeutic strategies by resolving the tumor ecosystem
Benjamin Izar(Columbia University Irving Medical Center), Aviv Regev(Broad Institute), Christopher Rodman(Broad Institute), Genevieve M. Boland(Harvard University), Rachel Leeson(Dana-Farber Cancer Institute), Charles H. Yoon(Brigham and Women's Hospital), Abhay Kanodia(Dana-Farber Cancer Institute), E.M. Van Allen(Dana-Farber Cancer Institute), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Parin Shah(The University of Texas MD Anderson Cancer Center), Dirk Schadendorf(National Center for Tumor Diseases), Asaf Rotem(AstraZeneca (South Korea)), Johannes C. Melms(Columbia University Irving Medical Center), Michael C. Cuoco(Broad Institute), Jia‐Ren Lin(Harvard University), Levi A. Garraway(Broad Institute), Peter K. Sorger(Harvard University Press), Livnat Jerby‐Arnon(Broad Institute), Gao Zhang(Central South University), F. Stephen Hodi(Harvard University), Mei-Ju Su(Harvard University), Orit Rozenblatt‐Rosen(Broad Institute), Itay Tirosh(Weizmann Institute of Science)
Cited by 0
Related Papers
Full-length transcriptome assembly from RNA-Seq data without a reference genome
|Nature Biotechnology|2011|22.7k
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis
|Nature Protocols|2013|9.1k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Spatial reconstruction of single-cell gene expression data
|Nature Biotechnology|2015|7.6k